Peptides for Weight Loss — Research Overview

What people mean by "peptides for weight loss"

The phrase usually refers to one of two groups:

• FDA-approved peptide medications prescribed for chronic weight management (most notably GLP-1 receptor agonists like semaglutide and tirzepatide).
• Research peptides discussed online for metabolic effects, most of which are not FDA-approved for weight loss.

GLP-1 receptor agonists

GLP-1 receptor agonists are peptide-based medications that work in the gut-brain axis. Several are FDA-approved for type 2 diabetes and for chronic weight management in eligible patients.

These are prescription medications. Access requires a licensed clinician and a compliant pharmacy.

Compounded GLP-1s

During periods of FDA-declared drug shortages, compounding pharmacies have prepared GLP-1 medications under specific rules. The legal status has evolved with shortage determinations and FDA enforcement priorities.

For details, see our Compounded Peptides Explained page.

Other peptides studied for metabolism

Beyond GLP-1s, researchers have studied other peptides for metabolic effects — including MOTS-c and certain growth-factor-related peptides. These are largely investigational and not FDA-approved for weight loss.

What this means in practice

If weight loss is your goal, evidence-based pathways include:

1. A licensed clinician's evaluation — to identify medical, behavioral, and metabolic factors
2. Lifestyle interventions — nutrition, sleep, movement, stress
3. FDA-approved medications when clinically appropriate
4. Long-term follow-up — weight management is a chronic process

Join the MedTideUSA waitlist for updates on peptide-related options as access evolves.